Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
168.62
+3.11 (1.88%)
At close: Feb 27, 2026, 4:00 PM EST
168.92
+0.30 (0.18%)
After-hours: Feb 27, 2026, 4:27 PM EST

Novartis AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
315,802265,212195,695207,167194,448197,007
Market Cap Growth
48.39%35.52%-5.54%6.54%-1.30%-8.39%
Enterprise Value
340,741288,115212,877220,692204,644224,014
Last Close Price
165.51137.8795.0496.2879.6274.78
PE Ratio
23.5818.9716.3913.9527.968.20
PS Ratio
5.574.683.784.444.474.48
PB Ratio
6.785.704.434.433.272.91
P/TBV Ratio
-----21.01
P/FCF Ratio
17.9515.0712.0415.4614.6014.07
P/OCF Ratio
16.5013.8511.1114.3313.6613.07
EV/Sales Ratio
6.015.084.124.734.715.09
EV/EBITDA Ratio
14.5212.2710.3012.1514.6814.33
EV/EBIT Ratio
17.9315.1613.0421.5722.2120.43
EV/FCF Ratio
19.3616.3713.1016.4715.3616.00
Debt / Equity Ratio
0.760.760.710.570.470.46
Debt / EBITDA Ratio
1.491.491.501.441.971.95
Debt / FCF Ratio
2.022.021.931.972.102.22
Net Debt / Equity Ratio
0.510.510.410.270.160.04
Net Debt / EBITDA Ratio
1.021.020.870.680.660.18
Net Debt / FCF Ratio
1.361.361.110.920.690.21
Asset Turnover
0.530.530.510.430.350.34
Inventory Turnover
2.272.272.201.911.671.65
Quick Ratio
0.820.820.780.881.001.25
Current Ratio
1.121.121.031.161.291.51
Return on Equity (ROE)
30.81%30.81%26.27%16.15%9.51%36.80%
Return on Assets (ROA)
11.14%11.14%10.09%5.88%4.62%5.28%
Return on Invested Capital (ROIC)
23.60%24.47%23.55%15.05%11.14%13.29%
Return on Capital Employed (ROCE)
22.70%22.70%22.20%13.90%10.40%10.80%
Earnings Yield
4.43%5.27%6.10%7.17%3.58%12.19%
FCF Yield
5.57%6.64%8.30%6.47%6.85%7.11%
Dividend Yield
1.84%3.38%4.06%4.07%4.35%4.55%
Payout Ratio
43.39%55.91%63.85%48.85%107.92%30.67%
Buyback Yield / Dilution
3.93%3.93%2.73%4.78%2.79%1.57%
Total Shareholder Return
5.76%7.32%6.79%8.85%7.13%6.12%
Updated Feb 4, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q